The days of browsing the aisles of the health food stores in search of a diet pill that may or may not work are dwindling fast. Green coffee bean extract, raspberry ketones, and garcinia cambogia simply can’t match the proven results promised by GLP-1 medications. The resulting surge in popularity is clear. Research foundation Nesta put the number of UK adults using GLP-1 drugs such as Ozempic (semaglutide), WeGovy (semaglutide) and Mounjaro (tirzepatide) at 1.6 million earlier this year.